Onbrez Articles

Lupin in deal to market Novartis' Onbrez in India, local newspaper reports

30 July 2012

Eisai in deal with Novartis to co-promote COPD drugs in Japan

21 November 2011

Novartis gets US and Japanese approval for COPD drug Arcapta/Onbrez

4 July 2011

Novartis COPD drug indacaterol gets mixed message from FDA advisory committee

9 March 2011

Novartis’ Onbrez plus Spiriva improves lung function in COPD patients

11 February 2011

Novartis’ Onbrez Breezhaler beats Spiriva in new study of COPD patients; Afinitor reduces SEGAs size

4 November 2010

Novartis pulls European marketing authorization application for aliskiren and valsartan combo Rasival; presents new data on Onbrez Breezhaler

20 September 2010

UK sees launch of Novartis COPD drug Onbrez Breezhaler, which Scotland clears for NHS use

11 August 2010

Novartis’ Onbrez Breezhaler significantly reduces COPD patient need for “relief” medication

19 May 2010

Showing 1-9 of 9 articles

Go to beginningPrevious
  • 1
NextGo to end